- Investing Ideas
- /
- U.S. Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Strong Past Earnings Growth, P/E Ratio Below 20
Results
128
8 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
128 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BRK.A | US$687,441.80 | 0.5% | 26.5% | US$988.8b | US$746,755.25 | PE9.2x | E-41.6% | n/a | Diversified Financials | ||
QCOM | US$159.36 | 0.9% | 9.6% | US$177.0b | US$204.70 | PE17.5x | E7.1% | 2.1% | Semiconductors | ||
CB | US$276.54 | -0.05% | 24.5% | US$111.5b | US$300.80 | PE11.2x | E2.2% | 1.3% | Insurance | ||
JD | US$36.46 | -2.2% | 32.1% | US$52.8b | US$48.76 | PE11x | E8.4% | 2.0% | Retail | ||
BKR | US$40.79 | -1.5% | 17.3% | US$40.4b | US$46.68 | PE18x | E10.6% | 2.1% | Energy | ||
HIG | US$110.57 | 1.4% | 38.6% | US$32.1b | US$129.00 | PE10.7x | E7.4% | 1.9% | Insurance | ||
CNC | US$60.83 | 5.2% | -17.4% | US$30.7b | US$79.39 | PE10x | E3.4% | n/a | Healthcare | ||
HPE | US$21.89 | 1.6% | 27.0% | US$28.8b | US$24.31 | PE11.3x | E0.6% | 2.4% | Tech | ||
TROW | US$117.07 | -0.7% | 7.7% | US$26.0b | US$115.79 | PE12.7x | E0.3% | 4.2% | Diversified Financials | ||
SYF | US$66.62 | -0.8% | 74.1% | US$25.9b | US$71.01 | PE8.4x | E-5.6% | 1.5% | Diversified Financials | ||
BF.B New | US$39.88 | -6.7% | -30.9% | US$18.7b | US$47.78 | PE18.8x | E3.7% | 2.3% | Food, Beverage & Tobacco | ||
KSPI | US$98.23 | -4.2% | 9.1% | US$18.7b | US$133.84 | PE9.9x | E23.7% | 6.7% | Diversified Financials | ||
L | US$84.80 | 1.4% | 22.9% | US$18.5b | n/a | PE11x | n/a | 0.3% | Insurance | ||
CSL New | US$376.45 | -7.0% | 19.8% | US$17.0b | US$486.67 | PE19.1x | E6.3% | 1.1% | Capital Goods | ||
MOH | US$295.19 | 1.2% | -17.5% | US$16.9b | US$360.77 | PE14.8x | E14.4% | n/a | Healthcare | ||
UTHR | US$360.87 | -5.0% | 66.9% | US$16.1b | US$393.74 | PE14.5x | E9.7% | n/a | Pharmaceuticals & Biotech | ||
EG | US$362.38 | 2.1% | 3.2% | US$15.6b | US$425.75 | PE5.7x | E8.6% | 2.2% | Insurance | ||
UNM | US$73.34 | 0.7% | 62.6% | US$13.4b | US$76.73 | PE7.6x | E-3.9% | 2.3% | Insurance | ||
CNA | US$48.62 | 0.5% | 15.7% | US$13.2b | US$50.00 | PE10.1x | E15.8% | 7.7% | Insurance | ||
NVT New | US$69.82 | -3.9% | 18.4% | US$11.5b | US$84.80 | PE19.9x | E0.6% | 1.1% | Capital Goods | ||
AIZ | US$215.43 | 1.1% | 29.5% | US$11.0b | US$233.20 | PE14.9x | E14.5% | 1.3% | Insurance | ||
SF | US$107.28 | 0.09% | 54.9% | US$11.0b | US$112.75 | PE17.9x | E13.1% | 1.6% | Diversified Financials | ||
SEIC New | US$84.46 | -0.8% | 30.8% | US$10.9b | US$80.80 | PE19.9x | E7.0% | 1.2% | Diversified Financials | ||
TTC New | US$80.85 | -5.2% | -18.8% | US$8.2b | US$93.20 | PE19.5x | E5.9% | 1.9% | Capital Goods |